Anthony W. Tolcher, M.D., FRCPC, FACP
CEO & Founder
Dr. Anthony Tolcher is a medical oncologist and co-founder of NEXT Oncology. He is dedicated to the development of new anticancer agents — including clinical trials and therapies — for patients looking for their next option now that their current cancer therapy is no longer working to their benefit. Dr. Tolcher is proud that the NEXT Oncology team scours the world to bring the best new agents back to its patients and centers.
This is much more than a job for Dr. Tolcher. It is his life’s work.
He is a graduate of the University of British Columbia in Vancouver, Canada. He performed his residency in internal medicine at the University of Toronto and his fellowship in oncology at the University of British Columbia. He followed this with a research fellowship at the National Cancer Institute in Bethesda, Maryland.
He was a Fogarty Fellow at the National Institute of Health and received the Murray Muirhead Award for humanitarian and academic excellence and the Goel Prize in Medicine for excellence in the Clinical Disciplines. He is a Fellow of the Royal College of Physicians of Canada; a Diplomate of the American Board of Internal Medicine and Medical Oncology; and a member of the American College of Physicians, and the American Society of Clinical Oncologists. He also serves as a member of the American Society of Clinical Oncology Scientific Program Committee and the Cancer Education Committee.